Validation Data Gallery
Tested Applications
| Positive WB detected in | Raji cells, human placenta tissue, human spleen tissue, A431 cells | 
| Positive IP detected in | A431 cells | 
| Positive IHC detected in | human tonsillitis tissue, human placenta tissue,  human skin cancer tissue,  human spleen tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 | 
Recommended dilution
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 | 
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate | 
| Immunohistochemistry (IHC) | IHC : 1:200-1:1200 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Published Applications
| KD/KO | See 1 publications below | 
| WB | See 2 publications below | 
| IHC | See 7 publications below | 
| IF | See 1 publications below | 
Product Information
14670-1-AP targets HLA-F in WB, IHC, IF, IP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human | 
| Cited Reactivity | human, mouse, rat | 
| Host / Isotype | Rabbit / IgG | 
| Class | Polyclonal | 
| Type | Antibody | 
| Immunogen | CatNo: Ag6335 Product name: Recombinant human HLA-F protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 21-298 aa of BC062991 Sequence: AGSHSLRYFSTAVSRPGRGEPRYIAVEYVDDTQFLRFDSDAAIPRMEPREPWVEQEGPQYWEWTTGYAKANAQTDRVALRNLLRRYNQSEAGSHTLQGMNGCDMGPDGRLLRGYHQHAYDGKDYISLNEDLRSWTAADTVAQITQRFYEAEEYAEEFRTYLEGECLELLRRYLENGKETLQRADPPKAHVAHHPISDHEATLRCWALGFYPAEITLTWQRDGEEQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPQPLILRWEQS相同性解析による交差性が予測される生物種 | 
| Full Name | major histocompatibility complex, class I, F | 
| Calculated molecular weight | 39 kDa | 
| Observed molecular weight | 40-45 kDa | 
| GenBank accession number | BC062991 | 
| Gene Symbol | HLA-F | 
| Gene ID (NCBI) | 3134 | 
| RRID | AB_1519280 | 
| Conjugate | Unconjugated | 
| Form | |
| Form | Liquid | 
| Purification Method | Antigen affinity purification | 
| UNIPROT ID | P30511 | 
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol{{ptg:BufferTemp}}7.3 | 
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. | 
Background Information
Human major histocompatibility complex (MHC) antigens, also referred to as human leukocyte antigens (HLA), are encoded by genes located on the short arm of chromosome 6 (6p21.3). There are two classes of HLA antigens: class I and class II. This class I molecules are membrane glycoproteins composed of a heavy (alpha) chain which is encoded by a HLA class I gene, and β2-microglobulin light (beta) chain. The most extensively characterized members of the HLA class I gene family are the genes encoding the major transplantation antigenes, HLA-A, B and C. HLA-F is a non-classical MHC class I molecule. (PMID: 667938; 3375250; 2249951)
Protocols
| Product Specific Protocols | |
|---|---|
| IP protocol for HLA-F antibody 14670-1-AP | Download protocol | 
| WB protocol for HLA-F antibody 14670-1-AP | Download protocol | 
| IHC protocol for HLA-F antibody 14670-1-AP | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
| Kidney Int Upregulation of HLA-F expression by BK polyomavirus infection induces immune recognition by KIR3DS1-positive natural killer cells. | ||
| Int J Cancer Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma. | ||
| J Immunol Immune Modifications in Fetal Membranes Overlying the Cervix Precede Parturition in Humans. | ||
| Int J Biol Sci Targeting HLA-F suppresses the proliferation of glioma cells via a reduction in hexokinase 2-dependent glycolysis.
 | ||
| Lung Cancer HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer. | ||
| Oncol Lett Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma. | 














